Pirfenidone in idiopathic pulmonary fibrosis - Wikidata - wikimedia - TriplyDB

Pirfenidone in idiopathic pulmonary fibrosis

Pirfenidone in idiopathic pulmonary fibrosis

http://www.wikidata.org/entity/Q28267108

about

The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation Silicosis appears inevitable among former denim sandblasters: a 4-year follow-up study Non-steroid agents for idiopathic pulmonary fibrosis Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy Therapeutic Approach to Adult Fibrotic Lung Diseases Pharmacological management of IPF New perspectives on management of idiopathic pulmonary fibrosis Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis Clinical trials of investigational agents for IPF: a review of a Cochrane report Acute and subacute idiopathic interstitial pneumonias TGF-β signaling via TAK1 pathway: role in kidney fibrosis Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis Cell-based therapy in lung regenerative medicine Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers Molecular biomarkers in idiopathic pulmonary fibrosis Idiopathic Pulmonary Fibrosis: Treatment and Prognosis Update on diagnosis and treatment of idiopathic pulmonary fibrosis Update on therapeutic management of idiopathic pulmonary fibrosis An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis Epidemiology and management of common pulmonary diseases in older persons Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials Predicting pulmonary fibrosis disease course from past trends in pulmonary function.Evolving therapies for liver fibrosis.Idiopathic pulmonary fibrosis--a systematic review on methodology for the collection of epidemiological data Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients.Double-blind controlled trial of lecithinized superoxide dismutase in patients with idiopathic interstitial pneumonia - short term evaluation of safety and tolerability.Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.Idiopathic pulmonary fibrosis in East Asian.Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.Advances in the management of idiopathic pulmonary fibrosis.Lymphoid tissue damage in HIV-1 infection depletes naïve T cells and limits T cell reconstitution after antiretroviral therapy.

P2860

Q21195756-AB2B9873-61A0-44AA-A719-997DF0B671FF Q23918200-B15F4051-F5EF-4853-990F-400AD21ABDFB Q24235478-C9F9E92F-F978-4154-ABC3-33F506B56075 Q26738458-44DFCECE-2B5A-4835-AB3A-0B381A016021 Q26741569-49C7333A-2362-430D-9CCB-FACC3BC5F25F Q26748808-5844F6F3-9B36-4E6F-A735-8BBD900A48A7 Q26765586-ADF8B3DF-855F-43E7-B0CD-29A22A8F4F85 Q26771309-054F277D-324E-49F5-864C-B69BFD3411DC Q26771647-A8B7D796-5B0B-462D-A7D8-91E14F70C3D3 Q26773161-37453279-47C0-4BDF-A440-254B40C12707 Q26777928-2708348E-3B43-4029-BC1E-2D486F985ED1 Q26783169-897AA165-7585-4F5D-9760-988FDEF4BFF0 Q26797272-F7BEBD3A-BC9A-44A4-8A8B-445806E58B88 Q26823161-A28CC302-FD7C-44A6-B80C-F883DAFCF7DD Q26824327-0784E787-DF25-407F-867B-0827AD51E5F9 Q26824337-BB03FF68-931B-4998-B2DB-2D5B28BEE0F9 Q26824810-DFA1C2DB-8ED6-4B79-9FD8-4F5B7BEDDD53 Q26849378-D83EF43E-79E4-4B5B-ACE0-89F7DDFBB68B Q26852285-7B900F6D-7C04-4E2D-B7EF-5B3099D0DCAF Q26864836-8E21AD83-5A22-4D44-9760-72C313A1C81B Q27025340-00CD943D-F5B9-4D35-AE97-82B01F000845 Q28073641-4A0D9102-001F-4AC3-8FB6-93E6FC640CBD Q28083702-E05B44A7-E716-4E8E-8A7D-B939C80CAFB4 Q28083944-ADD9761A-0025-44DA-81A0-7DB24928EB34 Q28308246-4A3A7DC4-8FCF-4964-97B5-C8D43CB1116E Q28308276-9E09B453-EBD1-40D9-801D-C9E76D498FF3 Q28397465-230A1FF9-8D1A-4D01-ADE6-FB4DFE5C4D86 Q28484304-CBF03357-2EA8-4C6A-A184-954826CFF46E Q30407660-12E43258-EAA3-4001-B64E-F829392F53F7 Q30539166-CEF9AE9A-B484-480C-9B51-F64B3F07ED75 Q30662543-32BF799F-1EE4-4DFA-9CFA-F01D4B265640 Q31030917-D72E3A0E-6449-4E34-B60C-2358A346B5AE Q31042134-00E5C933-7ED7-4FC0-B803-021C16334549 Q31108356-6A218B8B-97C7-4AD6-8E2E-1A6F88BBACD0 Q33657810-E51F8AB5-6E8E-4ED3-858F-C966B969DAAC Q33738724-C1B077C3-45B2-4DD5-B0BD-FB378C1FE025 Q33747908-5F263A2E-FFED-4286-AC55-C7365C9BBB5C Q33749957-10AC2DF1-3F90-45FE-876F-4C322EB4B054 Q33814226-38CF09CC-237E-4D30-A457-AA9688BE1503 Q34126302-1BB3F252-9C70-4203-BB0C-AED5C5E0A2DA

P2860

Pirfenidone in idiopathic pulmonary fibrosis

http://www.wikidata.org/entity/Q28267108

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pirfenidone in idiopathic pulmonary fibrosis

@ast

Pirfenidone in idiopathic pulmonary fibrosis

@en

Pirfenidone in idiopathic pulmonary fibrosis

@nl

type

label

Pirfenidone in idiopathic pulmonary fibrosis

@ast

Pirfenidone in idiopathic pulmonary fibrosis

@en

Pirfenidone in idiopathic pulmonary fibrosis

@nl

prefLabel

Pirfenidone in idiopathic pulmonary fibrosis

@ast

Pirfenidone in idiopathic pulmonary fibrosis

@en

Pirfenidone in idiopathic pulmonary fibrosis

@nl

P1433

Q28267108-2607AE17-82AB-4094-A03C-A89BCBF0655B

P1476

Q28267108-0AF987D2-ED8A-4F94-A294-76172206E6AD

P2093

Q28267108-2609E244-0704-4BAA-9613-25D28D4993BA

Q28267108-454E6F64-D074-4213-BC33-2F71652596DA

Q28267108-56C8A9C5-E804-443D-BE1D-7CAD6532940E

Q28267108-58F71EF2-F44C-49E3-8715-9AE1F7DA5E23

Q28267108-5A0284B4-C306-4574-A2B7-63CE440D32F8

Q28267108-890064C0-0F64-4FB4-883B-626FC8F9BE05

Q28267108-9BF39CE9-9807-4110-A4A6-256F9B442EA0

Q28267108-A3E83D01-8B80-4750-A328-D1D31A19D82D

Q28267108-B1D20452-246F-42C1-8630-83B30696150B

Q28267108-B5CAA2CE-4BF3-4D4E-BF8F-29E56B073033

P304

Q28267108-4277A14E-38BC-4332-888D-B7789C131E7F

P31

Q28267108-7CDAAFF6-EAB9-42F6-95B6-AE95D97A555C

P3181

Q28267108-8ECBDE1F-3738-4437-B80D-D19288EA99F1

P356

Q28267108-F5A39612-9BD3-4971-AB28-27C9E123089F

P407

Q28267108-88085081-0ADC-4F7D-87F6-435C32772053

P433

Q28267108-394B90A4-9933-4AB0-92BD-7A34A5FC6314

P478

Q28267108-3B7C1BC5-6CAF-476C-8D8D-308FF979BF71

P577

Q28267108-56F07D67-74A2-4525-B55F-D8E2137FC2F2

P5875

Q28267108-6D9686C8-3B9E-45CF-9B18-7198B1532B38

P698

Q28267108-BAD57CB8-6D52-4065-86AA-3892E3CE7875

P921

Q28267108-0C97DAE9-C1C9-4416-BD27-2C6DF4CE1ADB

Q28267108-8FDD0E94-D866-4509-B2D9-F09310BC02B7

P3181

P356

09031936.00005209

P1433

European Respiratory Journal

P1476

Pirfenidone in idiopathic pulmonary fibrosis

@en

P2093

A Azuma

http://www.w3.org/2001/XMLSchema#string

A Sato

http://www.w3.org/2001/XMLSchema#string

G Raghu

http://www.w3.org/2001/XMLSchema#string

H Takahashi

http://www.w3.org/2001/XMLSchema#string

H Taniguchi

http://www.w3.org/2001/XMLSchema#string

K Nakata

http://www.w3.org/2001/XMLSchema#string

M Ebina

http://www.w3.org/2001/XMLSchema#string

M Suga

http://www.w3.org/2001/XMLSchema#string

M Takeuchi

http://www.w3.org/2001/XMLSchema#string

S Kudoh

http://www.w3.org/2001/XMLSchema#string

P304

821-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

10759

http://www.w3.org/2001/XMLSchema#string

P356

10.1183/09031936.00005209

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40483027

http://www.w3.org/2001/XMLSchema#string

P698

19996196

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis